Stocks Health care IOBTQ
OTC · Health careIO Biotech, Inc. (IOBTQ)
It posted a net loss of $88.3M. In fiscal 2024 capital spending exceeded operating cash flow by $82.4M. At September 30, 2025 it held $30.7M in cash against $16.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 14, 2025.
Key facts about IO Biotech, Inc.
- Net worth
- IO Biotech, Inc. has a market value (market cap) of $7.2K at the latest share price, and shareholders' equity of $911K on its balance sheet at September 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2024 operations used $82.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 14, 2025 and covers the period to September 30, 2025. Open on SEC EDGAR
What IO Biotech, Inc. does
IO Biotech, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker IOBTQ.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | n/a | -$95.5M | -$1.45 | -$82.4M |
| 2023 | n/a | -$86.1M | -$1.98 | -$72.1M |
| 2022 | n/a | -$71.5M | -$2.48 | -$60.4M |
| 2021 | n/a | -$67.9M | -$17.30 | -$40.8M |
| 2021 | n/a | -$12M | -$82.36 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What IO Biotech, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- June 8, 2026Delisting notice 25-NSE
- June 2, 2026Activist stake changed SCHEDULE 13D/A
- May 20, 2026Passive stake changed SCHEDULE 13G/A
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- April 6, 2026Passive stake changed SCHEDULE 13G/A
- March 31, 2026
- February 13, 2026
- February 13, 2026Passive stake changed SCHEDULE 13G/A
- February 6, 2026Passive stake (5% or more) SCHEDULE 13G
- January 30, 2026
Insider trades
What the people running IO Biotech, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns IOBTQ
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Lundbeckfond Invest A/S13D, may seek influence | 27.4% | June 2, 2026 |
Largest institutional holders
Insiders
Questions about IOBTQ
What does IO Biotech, Inc. do?
IO Biotech, Inc. is a company in the Health care sector, listed on OTC as IOBTQ. Its shares trade on OTC under the ticker IOBTQ.
What is IO Biotech, Inc.'s net worth?
IO Biotech, Inc. has a market value (market cap) of $7.2K at the latest share price, and shareholders' equity of $911K on its balance sheet at September 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is IO Biotech, Inc. profitable?
No. Over the twelve months to September 30, 2025 it reported a net loss of $88.3M.
When did IO Biotech, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 14, 2025. It covers the period to September 30, 2025. Its newest filing of any kind is the delisting notice from June 8, 2026.
Similar companies
Compare IOBTQ with
Compare IOBTQ with any company
Follow IOBTQ
Get an email when IO Biotech, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values IO Biotech, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.